Structures by: Prasad K. J.
Total: 15
C24H18N4O2
C24H18N4O2
Organic & biomolecular chemistry (2018) 16, 14 2527-2540
a=8.7409(5)Å b=9.6037(6)Å c=12.1665(7)Å
α=72.299(4)° β=87.366(4)° γ=72.955(5)°
C23H16N4O2
C23H16N4O2
Organic & biomolecular chemistry (2018) 16, 14 2527-2540
a=8.3973(8)Å b=8.5161(9)Å c=14.1035(13)Å
α=97.848(6)° β=104.222(6)° γ=108.609(6)°
7,8,9,10-Tetrahydro-2-methylcyclohepta[<i>b</i>]indol-6(5<i>H</i>)-one
C14H15NO
Acta Crystallographica Section E (2008) 64, 7 o1207
a=11.461(3)Å b=6.5062(19)Å c=14.459(4)Å
α=90.00° β=92.310(4)° γ=90.00°
2,2-Dimethyl-2,3-dihydropyrano[2,3-<i>a</i>]carbazol-4(11<i>H</i>)-one
C17H15NO2
Acta Crystallographica Section E (2008) 64, 11 o2155
a=5.9926(5)Å b=14.3368(12)Å c=15.6839(13)Å
α=90.00° β=95.2700(10)° γ=90.00°
2,2,9-Trimethyl-2,3-dihydropyrano[2,3-<i>a</i>]carbazol-4-(11<i>H</i>)-one
C18H17NO2
Acta Crystallographica Section E (2008) 64, 11 o2156
a=8.6702(7)Å b=6.1647(5)Å c=26.617(2)Å
α=90.00° β=99.1000(10)° γ=90.00°
2,2,10-Trimethyl-2,3-dihydropyrano[2,3-<i>a</i>]carbazol-4(11<i>H</i>)-one
C18H17NO2
Acta Crystallographica Section E (2008) 64, 11 o2157
a=12.9740(16)Å b=9.4195(12)Å c=12.8444(16)Å
α=90.00° β=114.733(2)° γ=90.00°
7,8,9,10-Tetrahydrocyclohepta[<i>b</i>]indol-6(5<i>H</i>)-one
C13H13NO
Acta Crystallographica Section E (2008) 64, 9 o1697
a=14.0914(4)Å b=8.0883(2)Å c=9.2503(3)Å
α=90° β=108.937(3)° γ=90°
Carbazol derivative
C13H13NO2
Acta Crystallographica Section E (2008) 64, 4 o763-o764
a=9.0627(2)Å b=14.0285(3)Å c=8.5506(2)Å
α=90° β=101.8150(10)° γ=90°
Carbazol derivative
C12H10ClNO
Acta Crystallographica Section E (2008) 64, 8 o1635
a=10.4211(5)Å b=5.6851(3)Å c=17.0824(10)Å
α=90° β=100.239(6)° γ=90°
4-chloro-6-methyl-<i>N</i>-(4-methylphenyl)quinolin-2-amine
C17H15ClN2
Acta Crystallographica Section E (2011) 67, 2 o490
a=15.1445(13)Å b=11.4337(10)Å c=8.4764(7)Å
α=90.00° β=92.344(4)° γ=90.00°
9-Chloro-4-methyl-11-phenyl-5,6-diazatetracen-12(5<i>H</i>)-one
C23H15ClN2O
Acta Crystallographica Section E (2010) 66, 7 o1823
a=8.2434(2)Å b=8.5528(2)Å c=13.0740(3)Å
α=89.4460(10)° β=74.3620(10)° γ=77.6720(10)°
4-Chloro-2,5-dimethylquinoline
C11H10ClN
Acta Crystallographica Section E (2010) 66, 8 o2020
a=6.9534(9)Å b=13.0762(14)Å c=10.4306(11)Å
α=90.00° β=99.239(8)° γ=90.00°
7-(2-Chlorophenyl)-2,6,9-trimethyldibenzo[<i>b</i>,<i>h</i>][1,6]naphthyridine
C25H19ClN2
Acta Crystallographica Section E (2010) 66, 9 o2426-o2427
a=6.5575(4)Å b=10.6538(7)Å c=14.3522(9)Å
α=93.755(3)° β=103.099(3)° γ=102.074(3)°
2,9-Dimethyl-7-phenyl-<i>N</i>-(4-methylphenyl)dibenzo[<i>b</i>,<i>h</i>][1,6]naphthyridin-6-amine
C31H25N3
Acta Crystallographica Section E (2011) 67, 1 o102-o103
a=11.9390(4)Å b=10.5595(4)Å c=19.6084(7)Å
α=90.00° β=107.369(2)° γ=90.00°
7-(4-Methoxyphenyl)-4,9-dimethyl-<i>N</i>-(4-methylphenyl)-5,12-\ diazatetraphen-6-amine
C32H27N3O
Acta Crystallographica Section E (2011) 67, 4 o762-o763
a=8.3816(6)Å b=23.1651(13)Å c=12.8548(7)Å
α=90.00° β=91.171(3)° γ=90.00°